Clinical Trials

Clinical trials are a vital part of advancing modern cancer care. Our practice is deeply committed to providing patients access to the most innovative and promising therapies through high-quality research programs.

Our Leadership in Clinical Research

Professor Adnan Khattak is recognised as one of Australia’s leading medical oncologists, with an extensive international profile in early-phase and late-phase clinical trials. He has played a major role in bringing world-class research to Australia, including:

• The first personalised cancer vaccine trials conducted in Australia
• The first TIL (Tumour-Infiltrating Lymphocyte)–based cell therapy trials in Australia for both melanoma and lung cancer

His leadership continues to shape access to newest therapies long before they become available in standard practice.

Our Research Partnerships

Our practice is actively involved in many clinical trials through strong collaborations with:

• One Clinical Research (OCR)
• Ramsay Clinical Trial Unit
• Public Hospitals clinical trial units

Together, we participate in a broad range of early-phase (Phase I) and late-phase (Phase II–III) studies across multiple tumour types, ensuring patients have access to cutting-edge treatments that may not be available elsewhere.